OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toll-like receptors as a part of osteoarthritis pathophysiology: anti-inflammatory, analgesic and neuroprotective effects
I. Yu. Torshin, О. А. Громова, А. М. Лила, et al.
Neurology neuropsychiatry Psychosomatics (2021) Vol. 13, Iss. 4, pp. 123-129
Open Access | Times Cited: 12

Showing 12 citing articles:

Hepatoprotective peptides of the drug Laennec
I. Yu. Torshin, О. А. Громова, Olga V. Tikhonova, et al.
Experimental and Clinical Gastroenterology (2022), Iss. 7, pp. 21-30
Open Access | Times Cited: 9

Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate
I. Yu. Torshin, Т. Б. Минасов, N. V. Zagorodniy, et al.
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology (2022) Vol. 15, Iss. 1, pp. 162-169
Open Access | Times Cited: 8

Pharmaconutraceutical Chondroguard®TRIO – chondroprotector with immunomodulatory activity
О. А. Shavlovskaya, Yu. D. Yukhnovskaya, И. Д. Романов, et al.
Neurology neuropsychiatry Psychosomatics (2023) Vol. 15, Iss. 4, pp. 105-111
Open Access | Times Cited: 4

Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy
О. А. Shavlovskaya, О. А. Громова, A. Yu. Kochish, et al.
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology (2023) Vol. 16, Iss. 3, pp. 482-499
Open Access | Times Cited: 3

Chondroprotectors as modulators of neuroinflammation
I. Yu. Torshin, О. А. Громова, A G Nazarenko
Neurology neuropsychiatry Psychosomatics (2023) Vol. 15, Iss. 1, pp. 110-118
Open Access | Times Cited: 2

On the use of chondroitin sulfate, glucosamine sulfate and undenatured type II collagen for back and limb pain and osteoarthritis
О. А. Громова, I. Yu. Torshin, А. М. Лила
Neurology neuropsychiatry Psychosomatics (2022) Vol. 14, Iss. 6, pp. 122-130
Open Access | Times Cited: 4

The state of psychological and immunological indicators in graduate students of a medical university
И. И. Андреева, R. T. Urazmambetov, S. A. Chebotov
Russian Journal of Immunology (2024) Vol. 27, Iss. 4, pp. 811-818
Open Access

Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome)
I. Yu. Torshin, О. А. Громова, А. М. Лила
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology (2022) Vol. 15, Iss. 3, pp. 390-401
Open Access | Times Cited: 2

Important aspects of osteoarthritis therapy during the COVID-19 pandemic
А. М. Лила, А. Г. Чучалин, I. Yu. Torshin, et al.
Modern Rheumatology Journal (2022) Vol. 16, Iss. 1, pp. 108-114
Open Access | Times Cited: 1

Analysis of the mechanisms of development of neurorheumatological consequences of COVID-19 and the possibility of their pharmacological correction
И. В. Сарвилина, А. М. Лила, О. А. Громова, et al.
Modern Rheumatology Journal (2022) Vol. 16, Iss. 2, pp. 92-98
Open Access | Times Cited: 1

Chondroitin sulfate in therapy osteoarthritis chronic pain patients according to actual clinical recommendations
О. А. Shavlovskaya
Terapevticheskii arkhiv (2021) Vol. 93, Iss. 12, pp. 1551-1555
Open Access

Page 1

Scroll to top